However, a recent review article highlighted the down regulation of Sulf1 in early stage ovarian tumors and metastatic breast cancer patients (7) while assessment of Sulf2 using a cohort of breast cancer patients found significant upregulation in autologous metastatic lesion compared with primary tumors (122). This evidence concerns the gene SULF1 and breast carcinoma.